Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Latest News 
Medical notes 
Background Briefings 
Education 
Sport 
Entertainment 
Talking Point 
In Depth 
AudioVideo 
Wednesday, 29 December, 1999, 03:57 GMT
Stroke drugs 'could treat MS'

stroke patient Drug targeted at stroke could fight other brain diseases


Medicines being tested for possible benefits to stroke sufferers could also help tackle multiple sclerosis, claim researchers.

Scientists say they have found that increased levels of glutamate - a common amino acid - may be a common cause of brain damage in both diseases.

Glutamate acts as a neurotransmitter within the brain and is tightly regulated by the nervous system. The uncontrolled dumping of large amounts of glutamate is known to be a major cause of brain damage in stroke.



We can use the research which is already being done on stroke to get a head start in the treatment of MS
Professor Peter Werner
New evidence, reported in the journal Nature Medicine, now suggests that a similar mechanism may be involved in MS, where glutamate can act on the specialised brain cells that produce myelin, the insulation for nerve fibres.

Nerve damage

Using a mouse model of MS, scientists found that a glutamate receptor blocker, NBQX, prevents glutamate-induced nerve damage and protects myelin-making cells from destruction, according to the report.

This raises the possibility that compounds used experimentally for the treatment of stroke may also prove useful for the treatment of MS.

"If we can verify this, we can use the research which is already being done on stroke to get a head start in the treatment of MS," said Peter Werner, assistant professor of neurology at Albert Einstein College of Medicine, in New York.

"This new concept may eventually lead to a better treatment of the destruction of brain cells in MS," he said. "It will not stop MS, but it may help ameliorate the damage."

Multiple sclerosis, an inflammatory disease that affects nearly 1 million people worldwide, arises when the immune system mistakenly damages myelin in the brain and spinal cord.

Search BBC News Online

Advanced search options
Launch console
BBC RADIO NEWS
BBC ONE TV NEWS
WORLD NEWS SUMMARY
PROGRAMMES GUIDE

See also:
08 Dec 99 |  Health
Artificial nerves aid stroke patients
12 Oct 99 |  Health
Stroke care 'disorganised and haphazard'
02 Jul 99 |  Health
Stroke delays increase deaths
10 Dec 99 |  Health
MS drug 'should be restricted'
18 Sep 99 |  Health
Plasma treatment aids MS sufferers
09 Sep 99 |  Health
Race against time for MS drug

Internet links:

The BBC is not responsible for the content of external internet sites
Links to other Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories